Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
2.
United European Gastroenterol J ; 7(1): 21-44, 2019 02.
Article in English | MEDLINE | ID: mdl-30788114

ABSTRACT

The European Society of Gastrointestinal Endoscopy (ESGE) and United European Gastroenterology present a list of key performance measures for endoscopy services. We recommend that these performance measures be adopted by all endoscopy services across Europe. The measures include those related to the leadership, organization, and delivery of the service, as well as those associated with the patient journey. Each measure includes a recommendation for a minimum and target standard for endoscopy services to achieve. We recommend that all stakeholders in endoscopy take note of these ESGE endoscopy services performance measures to accelerate their adoption and implementation. Stakeholders include patients and their advocacy groups; service leaders; staff, including endoscopists; professional societies; payers; and regulators.


Subject(s)
Endoscopy, Gastrointestinal , Quality Improvement , Quality of Health Care , Endoscopy, Gastrointestinal/adverse effects , Endoscopy, Gastrointestinal/methods , Endoscopy, Gastrointestinal/standards , Europe , Health Care Surveys , Humans , Practice Guidelines as Topic , Quality Assurance, Health Care
3.
Endoscopy ; 50(12): 1186-1204, 2018 12.
Article in English | MEDLINE | ID: mdl-30423593

ABSTRACT

The European Society of Gastrointestinal Endoscopy (ESGE) and United European Gastroenterology present a list of key performance measures for endoscopy services. We recommend that these performance measures be adopted by all endoscopy services across Europe. The measures include those related to the leadership, organization, and delivery of the service, as well as those associated with the patient journey. Each measure includes a recommendation for a minimum and target standard for endoscopy services to achieve. We recommend that all stakeholders in endoscopy take note of these ESGE endoscopy services performance measures to accelerate their adoption and implementation. Stakeholders include patients and their advocacy groups; service leaders; staff, including endoscopists; professional societies; payers; and regulators.


Subject(s)
Endoscopy, Gastrointestinal/standards , Quality Improvement , Quality Indicators, Health Care , Safety/standards , Endoscopy, Gastrointestinal/adverse effects , Equipment and Supplies/standards , Health Facilities/standards , Humans , Informed Consent/standards , Leadership , Patient Comfort/standards , Patient Education as Topic/standards , Patient Participation , Patient Selection , Privacy , Referral and Consultation/standards , Workforce/standards
4.
J Crohns Colitis ; 12(12): 1438-1447, 2018 Nov 28.
Article in English | MEDLINE | ID: mdl-30202856

ABSTRACT

BACKGROUND: During surveillance colonoscopy of patients with long-standing ulcerative colitis [UC], a variety of dysplastic and non-dysplastic lesions are detected. The aim of this study was to address the diagnostic accuracy of endoscopic characterization of endoscopic trimodal imaging [ETMI] and chromoendoscopy [CE]. ETMI includes the combination of autofluorescence imaging [AFI], narrow band imaging [NBI] and white light endoscopy [WLE]. METHODS: This is a pre-specified additional analysis of a multi-centre, randomized controlled trial that compared AFI with CE for dysplasia detection in 210 patients with long-standing UC [FIND-UC trial]. In the AFI arm, endoscopists used the ETMI system to record AFI colour, Kudo pit pattern using NBI and WLE for lesion characterization. For AFI, purple colour and ambiguous colour combined with pit pattern type III-V on NBI was considered dysplastic. Kudo pit pattern was described in the CE arm. For pit pattern description using NBI and CE, type III-V was considered dysplastic. Histology was the reference standard. RESULTS: In total, 52 dysplastic and 255 non-dysplastic lesions were detected. Overall sensitivity for real-time prediction of dysplasia was 76.9% (95% confidence interval [CI] 46.2-95.0) for ETMI, and 81.6% [95% CI 65.7-92.3] for CE. Overall negative predictive value [NPV] for ETMI was 96.9% [95% CI 92.0-98.8] and 94.7% [90.2-97.2] for CE. CONCLUSIONS: Sensitivity for endoscopic differentiation of dysplastic lesions detected during surveillance of patients with long-standing UC seems limited using ETMI and CE. Future research is warranted as the high NPV indicates that these techniques are valuable for the exclusion of dysplastic lesions [NTR4062].


Subject(s)
Colitis, Ulcerative , Colonic Polyps/diagnostic imaging , Colorectal Neoplasms/diagnostic imaging , Endoscopy, Digestive System/methods , Colitis, Ulcerative/complications , Colitis, Ulcerative/diagnosis , Colonic Polyps/etiology , Colorectal Neoplasms/etiology , Diagnosis, Differential , Disease Progression , Female , Humans , Male , Middle Aged , Multimodal Imaging/methods , Predictive Value of Tests , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...